Promisia Healthcare Limited (NZE:PHL)
New Zealand · Delayed Price · Currency is NZD 0.5300
+0.0200 (3.92%)
Nov 14, 2025, 3:56 PM NZST
Promisia Healthcare Income Statement
Financials in millions NZD. Fiscal year is April - March.
Millions NZD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 37.1 | 30.97 | 21.93 | 23.47 | 19 | 4.85 | Upgrade | |
Revenue Growth (YoY) | 55.13% | 41.20% | -6.54% | 23.53% | 291.83% | - | Upgrade |
Gross Profit | 37.1 | 30.97 | 21.93 | 23.47 | 19 | 4.85 | Upgrade |
Selling, General & Admin | 33.76 | 28.18 | 20.03 | 20.3 | 15.47 | 4.32 | Upgrade |
Operating Expenses | 34.29 | 28.59 | 20.81 | 21.14 | 16.28 | 4.62 | Upgrade |
Operating Income | 2.81 | 2.38 | 1.13 | 2.33 | 2.72 | 0.23 | Upgrade |
Interest Expense | -3.36 | -2.9 | -2.41 | -2.28 | -1.5 | -0.72 | Upgrade |
EBT Excluding Unusual Items | -0.55 | -0.52 | -1.28 | 0.05 | 1.22 | -0.49 | Upgrade |
Merger & Restructuring Charges | - | - | - | - | - | -0.72 | Upgrade |
Gain (Loss) on Sale of Assets | 0.11 | 0.11 | 0.78 | 0.37 | - | - | Upgrade |
Asset Writedown | -0.32 | -0.32 | 3.45 | 0.05 | -0.22 | 1 | Upgrade |
Other Unusual Items | 2.23 | 7.41 | - | - | 0.94 | - | Upgrade |
Pretax Income | 1.47 | 6.68 | 2.94 | 0.46 | 1.94 | -0.2 | Upgrade |
Income Tax Expense | 0.3 | 0.11 | 1.96 | -0.23 | -0.06 | -0.22 | Upgrade |
Earnings From Continuing Operations | 1.18 | 6.57 | 0.99 | 0.69 | 2.01 | 0.02 | Upgrade |
Earnings From Discontinued Operations | -0.17 | 0.26 | 0.65 | - | 0.02 | 0.02 | Upgrade |
Net Income | 1 | 6.84 | 1.64 | 0.69 | 2.03 | 0.04 | Upgrade |
Net Income to Common | 1 | 6.84 | 1.64 | 0.69 | 2.03 | 0.04 | Upgrade |
Net Income Growth | -86.77% | 318.10% | 136.27% | -65.86% | 4424.55% | - | Upgrade |
Shares Outstanding (Basic) | 51 | 49 | 43 | 43 | 42 | 14 | Upgrade |
Shares Outstanding (Diluted) | 57 | 56 | 43 | 43 | 42 | 14 | Upgrade |
Shares Change (YoY) | 72.37% | 30.93% | 0.36% | 0.54% | 199.85% | 264.54% | Upgrade |
EPS (Basic) | 0.02 | 0.14 | 0.04 | 0.02 | 0.05 | 0.00 | Upgrade |
EPS (Diluted) | 0.02 | 0.12 | 0.04 | 0.02 | 0.05 | 0.00 | Upgrade |
EPS Growth | -92.32% | 219.35% | 138.58% | -66.50% | 1409.36% | - | Upgrade |
Free Cash Flow | 4.38 | 3.12 | 7.17 | -6.81 | 4.31 | -2.63 | Upgrade |
Free Cash Flow Per Share | 0.08 | 0.06 | 0.17 | -0.16 | 0.10 | -0.19 | Upgrade |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade |
Operating Margin | 7.57% | 7.69% | 5.13% | 9.92% | 14.32% | 4.74% | Upgrade |
Profit Margin | 2.70% | 22.07% | 7.46% | 2.95% | 10.67% | 0.92% | Upgrade |
Free Cash Flow Margin | 11.80% | 10.07% | 32.67% | -29.03% | 22.67% | -54.22% | Upgrade |
EBITDA | 3.34 | 2.79 | 1.93 | 3.17 | 2.86 | 0.31 | Upgrade |
EBITDA Margin | 9.00% | 9.01% | 8.79% | 13.49% | 15.07% | 6.37% | Upgrade |
D&A For EBITDA | 0.53 | 0.41 | 0.8 | 0.84 | 0.14 | 0.08 | Upgrade |
EBIT | 2.81 | 2.38 | 1.13 | 2.33 | 2.72 | 0.23 | Upgrade |
EBIT Margin | 7.57% | 7.69% | 5.13% | 9.92% | 14.32% | 4.74% | Upgrade |
Effective Tax Rate | 20.29% | 1.60% | 66.45% | - | - | - | Upgrade |
Revenue as Reported | 39.62 | 38.66 | 26.35 | 23.88 | 19.94 | 5.85 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.